OncologyVideos + subtitles + PDFs2026
Harvard Molecular Diagnostics Current Roles in Cancer Diagnosis 2026 — from sequencing pipeline to tumour board
Harvard Molecular Diagnostics Current Roles in Cancer Diagnosis 2026 records the April 13–15, 2026 Harvard course as 40 MP4 videos with VTT subtitles and 41 PDFs, a 5.47 GB download. It starts inside the lab — next-day NGS workflows, informatics architecture, variant-calling pipelines, TMB, MSI and HRD, indels and fusion detection — then moves tumour by tumour through sarcoma, gynaecologic, paediatric, brain, skin, breast, lung, thyroid, salivary and blood cancers. Closing sessions on AI, pharmacogenomics, reimbursement and lab leadership address how a molecular programme is built and kept running.
- 40videos
- 41PDFs
- 5.47 GBdownload
- 3course days
What you’ll be able to do
- Follow an NGS bioinformatics pipeline and know where calls can fail
- Interpret gene fusions found by RNA-based sequencing, including oncogenicity
- Weigh liquid biopsy and ctDNA against tissue testing for a given patient
- Read TMB, MSI, HRD and copy-number results in therapeutic context
- Decide when germline and tumour-normal paired testing is warranted
- Explain molecular findings clearly to tumour boards and patients
Inside the course
Platforms and informatics
Talks on integrated molecular oncology, faster treatment starts with next-day NGS, translating molecular findings into immunohistochemistry and practical bioinformatics lead into signatures, viral sequences, isoforms, sub-gene events and long-read sequencing.
Harvard Molecular Diagnostics across tumour types
Disease-focused sessions cover sarcoma fusions, GYN and paediatric tumours, gliomas with methylation profiling, melanoma, breast and lung testing, thyroid and salivary genomics, and myeloid, leukaemia and lymphoma diagnostics including MRD.
Cytogenomics, germline and case work
Copy-number analysis by NGS and microarray, technical and clinical cytogenomics, germline testing and paired sequencing are brought to life in a pathology–oncology case review, a tumour board simulation and a tissue-versus-liquid biopsy panel.
Running the lab
Pharmacogenomics, AI, a case-report writing workshop, patient advocacy, building a profiling programme, regulation and reimbursement, leadership challenges and future directions look beyond the bench.
Built for
- Molecular and surgical pathologistsDeepen sign-out skills for fusion, CNV and signature reports.
- Medical and haematologic oncologistsKnow which assay to order and how far to trust the result.
- Laboratory directorsInformatics, reimbursement and leadership sessions support launching or scaling a molecular service.
Faculty & syllabus
Released lectures 41 lectures
- Integrated Molecular Oncology in 2026 Trends and Tools for Gene Fusion Detection
- End-to-end Process to Accelerating Treatment Initiation with Next-day NGS
- Translation of Molecular to Immunohistochemistry
- Informatics Architecture
- NGS Pipelines Demystified Practical Bioinformatics
- Tumor Mutation Burden, MSI, and HRD
- Indel Detection
- Viral Sequence Detection and Other Signatures
- Gene Fusion Detection and Interpretation by RNA-based NGS a Practical, Cased-based Approach
- Additional Informatics Analyses Detection of Clinically Significant Isoforms and Sub-gene Events through RNA andor DNA-based NGS
- Oncogenicity Interpretation of Gene Fusions Detected by RNA-based NGS
- Applications of Long-Read Sequencing for Cancer Diagnostics
- Liquid Biopsy and ctDNA Technical and Clinical Perspectives
- Panel Discussion Tissue vs Liquid Biopsy
- Sarcoma and Fusion Testing
- Molecular Diagnostics for GYN Tumors
- Molecular Diagnostics for Pediatric Tumors
- GU Cancers Molecular Markers (PDF only)
- Copy Number Variation via NGS and Microarray
- Cytogenomics Technical Focus
- Cytogenomics Clinical Focus
- Gliomas and Methylation Profiling
- Germline Testing in Oncology What, When, and How
- Tumor-Normal Paired Sequencing Clinical Impact
- Case Review Pathology Oncology Perspectives
- Melanoma Molecular Pathology
- Molecular Diagnostics for Breast Cancer
- Tumor Board Simulation Real Case Review
- Myeloid Neoplasms and MRD Testing
- Leukemia Molecular Diagnostics (B- and T-cell)
- Molecular Diagnostics and Lymphoma
- Pharmacogenomics in Oncology Management
- Lung Tumor Testing
- Thyroid Cancer and Salivary Tumor Genomics
- AI in Molecular Oncology
- Interactive Workshop Case Report Writing and Communication
- The Power of Patient Partnership in Cancer Advocacy
- Building a Molecular Profiling Program
- Regulatory and Reimbursement Essentials
- Lab Leadership and Challenges
- Future Directions in Molecular Oncology
Before you buy
Is the whole agenda included?
Almost: the GI cancer case-based applications session was not released in any form, and the GU cancers molecular markers talk comes as PDF slides without video. Everything else on the 42-item programme is present.
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | MP4 videos · VTT subtitles · PDFs |
|---|---|
| Contents | 40 videos · 40 subtitle files · 41 PDFs |
| Size | 5.47 GB |
| Course dates | April 13–15, 2026 |
| Publisher | Harvard Medical School |
| Department | Oncology |
| Delivery | Instant download · lifetime re-download |
Related products
Critical Care / Emergency Medicine
Harvard Critical Issues in Tumor Microenvironment Angiogenesis, Metastasis and Immunology 2025
Oncology-Hematology
American Society of Hematology Self-Assessment Program, 9th edition (True PDF+Videos)
Harvard Medicine
Addiction Medicine
